Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (Q81963102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Keith Muir

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Nils Wahlgren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Antoni Dávalos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Werner Hacke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Mónica Millán

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Risto O Roine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Danilo Toni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Kennedy R Lees

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

SITS investigators

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

12 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

9646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

1303-1309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Guidelines for the Early Management of Adults With Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Two-sided confidence intervals for the single proportion: comparison of seven methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

Safety of routine IV thrombolysis between 3 and 4.5 h after ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961339-2

7 January 2021

10.1016/S0140-6736(08)61339-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18790527%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference